K5 Global — 2017 Investments
2 investments dated 2017 · listed companies and verified rows first · show all
Angiex develops Nuclear-Delivered Antibody-Drug Conjugate (ND-ADC) therapies for solid cancers, using a platform that delivers chemotherapeutic payloads to the nucleus of tumor cells and tumor blood vessel endothelial cells.
BiotechHealthtechMedical DevicesCambridge, US
Paul Jaminet(Founder & CEO)inShou-Ching Jaminet(Founder, Scientific Adviser)Hal Dvorak(Founder, SAB Chair)
BoardErrik Anderson(Director)Jason Camm(Director)inIain Dukes(Director)in
Co-investorsGaingelsGreen Meadow VenturesMana VenturesOrbiMed
Astronomer provides Astro, a platform for running Apache Airflow, the open-source data orchestration tool used by enterprises to manage AI, ML, and analytics pipelines at scale.
AI & Machine LearningCloud ComputingData & InfrastructureDeveloper ToolsCincinnati, US
Ry Walker(Founder)inViraj Parekh(Founder)inJoe Otto(Founder)inGreg Neiheisel(Founder)Tim Brunk(Founder)inRyan Walker(Executive Officer, Director)
Co-investors500 GlobalAngelPadBain Capital VenturesBosch VenturesCincyTechConnetic Ventures+13 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.




__Twitter.png)









